Engitix Therapeutics
Hattie Tingle has been working in the field since 2014, when they began volunteering with NHS England. Hattie then went on to become a Student Researcher at the University of Surrey in 2019 and is currently an Associate Scientist at Engitix Therapeutics since 2021.
Hattie Tingle attended the University of Bath from 2017 to 2021, where they earned a Master's degree in Pharmacology.
Engitix Therapeutics
To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.